Banque Cantonale Vaudoise Moderna, Inc. Transaction History

Banque Cantonale Vaudoise

$2.55 Billion
Q1 2024

A detailed history of Banque Cantonale Vaudoise transactions in Moderna, Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 27,885 shares of MRNA stock, worth $3.26 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

27,885

Previous 5 557600.0%

Holding current value

$3.26 Million

Previous $50,000 5846.0%

% of portfolio

0.12%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$85.37 - $115.44 $387,494 - $523,982	-4,539 Reduced 14.0%	27,885 $2.97 Million
Q4 2023 Feb 07, 2024	SELL	$69.51 - $104.43 $247,803 - $372,292	-3,565 Reduced 9.91%	32,424 $3.23 Million
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $273,129 - $358,686	2,833 Added 8.54%	35,989 $3.72 Million
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $230,838 - $312,712	-1,948 Reduced 5.55%	33,156 $4.03 Million
Q1 2023 Apr 20, 2023	BUY	$135.66 - $197.02 $415,526 - $603,472	3,063 Added 9.56%	35,104 $5.39 Million

Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $2.32 Million - $4.11 Million	-19,590 Reduced 37.94%	32,041 $5.76 Million
Q3 2022 Oct 17, 2022	SELL	$118.07 - $194.18 $405,334 - $666,619	-3,433 Reduced 6.23%	51,631 $6.1 Million
Q2 2022 Aug 02, 2022	SELL	$117.13 - $176.59 $747,875 - $1.13 Million	-6,385 Reduced 10.39%	55,064 $7.87 Million
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $852,593 - $1.58 Million	-6,742 Reduced 9.89%	61,449 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $5.43 Million - $8.87 Million	24,057 Added 54.51%	68,191 $17.3 Million
Q3 2021 Oct 29, 2021	SELL	$221.9 - $484.47 $3.68 Million - $8.04 Million	-16,601 Reduced 27.33%	44,134 $17 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $3.27 Million - $5.91 Million	25,158 Added 70.71%	60,735 $14.3 Million
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $2.11 Million - $3.6 Million	19,347 Added 119.21%	35,577 $4.66 Million
Q4 2020 Feb 05, 2021	BUY	$65.74 - $169.86 $31,555 - $81,532	480 Added 3.05%	16,230 $1.7 Million
Q3 2020 Oct 30, 2020	BUY	$54.34 - $94.85 $693,813 - $1.21 Million	12,768 Added 428.17%	15,750 $1.11 Million
Q2 2020 Jul 22, 2020	SELL	$29.67 - $80.0 $534 - $1,440	-18 Reduced 0.6%	2,982 $192,000
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $53,340 - $94,740	3,000 New	3,000 $90,000

Others Institutions Holding MRNA

# of Institutions

1,037

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Moderna, Inc. Transaction History